Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Submandibular Gland Neoplasms 1Parotid Neoplasms 1Multiple Pulmonary Nodules 1Breast Neoplasms 1

Interventions

pembrolizumab 1gadobutrol 1Standard of Care 1Radiotherapy 1Radiation 1Proton Therapy 1Practice Guidelines as Topic 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Limonene 1Erlotinib Hydrochloride 1Docetaxel 1Citric Acid 1Cisplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Parotid Neoplasms × Limonene × Clear all
NCT04296266 2020-03-05

Human Salivary Gland Disposition of Alda-341 in Patients Undergoing Salivary Gland Surgery

Stanford University

Phase EARLY_PHASE1 Completed
10 enrolled

Parotid Neoplasms, Submandibular Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡